We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$2.54B
Cap. Flow
+$1.55B
Cap. Flow %
7.41%
Top 10 Hldgs %
15.24%
Holding
2,978
New
379
Increased
824
Reduced
813
Closed
161

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$798M
2
XOM icon
ExxonMobil
XOM
+$189M
3
CTSH icon
Cognizant
CTSH
+$86.4M
4
MRK icon
Merck
MRK
+$80.6M
5
IART icon
Integra LifeSciences
IART
+$47.9M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$57.5M
2
PEP icon
PepsiCo
PEP
+$55.1M
3
DG icon
Dollar General
DG
+$49.7M
4
WOOF
VCA Inc.
WOOF
+$48.1M
5
SPG icon
Simon Property Group
SPG
+$45.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 14.11%
3 Financials 12.07%
4 Industrials 10.58%
5 Consumer Discretionary 9.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MET.PRA icon
1651
MetLife Inc Floating Rate Series A
MET.PRA
$504M
$19K ﹤0.01%
800
MSGS icon
1652
Madison Square Garden
MSGS
$9.54B
$19K ﹤0.01%
140
PIO icon
1653
Invesco Global Water ETF
PIO
$269M
$19K ﹤0.01%
888
PIZ icon
1654
Invesco Dorsey Wright Developed Markets Momentum ETF
PIZ
$718M
$19K ﹤0.01%
836
SH icon
1655
ProShares Short S&P500
SH
$916M
$19K ﹤0.01%
148
WPRT
1656
Westport Fuel Systems
WPRT
$36.4M
$19K ﹤0.01%
+2,000
New +$21.9K
AXE
1657
DELISTED
Anixter International Inc
AXE
$19K ﹤0.01%
246
+50
+26% +$4.08K
TNH
1658
DELISTED
Terra Nitrogen
TNH
$19K ﹤0.01%
200
BBT
1659
Beacon Financial Corp
BBT
$2.53B
$18K ﹤0.01%
527
HHH icon
1660
Howard Hughes
HHH
$3.93B
$18K ﹤0.01%
162
+39
+32% +$4.2K
HIMX
1661
Himax Technologies
HIMX
$2.2B
$18K ﹤0.01%
2,000
NYT icon
1662
New York Times
NYT
$11.6B
$18K ﹤0.01%
1,275
+275
+28% +$3.93K
TDY icon
1663
Teledyne Technologies
TDY
$30.4B
$18K ﹤0.01%
146
+50
+52% +$6.38K
THS
1664
DELISTED
Treehouse Foods
THS
$18K ﹤0.01%
224
-164
-42% -$13.1K
UGP icon
1665
Ultrapar
UGP
$6.87B
$18K ﹤0.01%
1,630
ZBRA icon
1666
Zebra Technologies
ZBRA
$12.4B
$18K ﹤0.01%
200
VIVO
1667
DELISTED
Meridian Bioscience Inc
VIVO
$18K ﹤0.01%
1,410
+210
+18% +$2.94K
MNDT
1668
DELISTED
Mandiant, Inc. Common Stock
MNDT
$18K ﹤0.01%
1,535
+335
+28% +$4K
WPX
1669
DELISTED
WPX Energy, Inc.
WPX
$18K ﹤0.01%
1,428
AER icon
1670
AerCap
AER
$23.9B
$17K ﹤0.01%
388
-1,426
-79% -$63.9K
AFG icon
1671
American Financial Group
AFG
$11.9B
$17K ﹤0.01%
180
ASX icon
1672
ASE Group
ASX
$80.8B
$17K ﹤0.01%
2,678
+573
+27% +$3.41K
BBD icon
1673
Banco Bradesco
BBD
$38.1B
$17K ﹤0.01%
3,430
+626
+22% +$3.31K
CNCR
1674
DELISTED
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
$17K ﹤0.01%
700
MED icon
1675
Medifast
MED
$108M
$17K ﹤0.01%
394
+94
+31% +$4.05K

Similar funds

Glenmede Trust's Q1 2017 Portfolio in Review

As of Q1 2017, Glenmede Trust held 2,978 positions worth $20.9B, up 14% from $18.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Glenmede Trust deployed $1.55B of net new capital in Q1 2017, opening 379 new positions and adding to 824 existing holdings. Its largest new stake was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Activision Blizzard, an estimated $57.5M trimmed.

  • Glenmede Trust's largest Q1 2017 buy was Pebblebrook Hotel Trust: 1,454,685 shares worth $42.4M.
  • Glenmede Trust added most to Johnson & Johnson in Q1 2017, an estimated $798M increase.
  • Glenmede Trust's biggest Q1 2017 reduction was Activision Blizzard, cutting an estimated $57.5M.
  • Glenmede Trust fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $22.5M.
  • Glenmede Trust's ten largest holdings make up 15% of its $20.9B portfolio in Q1 2017.
  • Glenmede Trust opened 379 new positions and closed 161 in Q1 2017.
  • Glenmede Trust's portfolio value rose 14% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q1 2017, filed 15 May 2017.